Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin (TECH, CEPH, ILMN, TLCR)

Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Techne Corporation TECH is 57.32%. TECH's ROE for the same period is 21.58%. The trailing-twelve-month operating margin at Cephalon Inc CEPH is 30.61%. CEPH's revenue for the same period is $2.81 billion. The trailing-twelve-month operating margin at Illumina Inc ILMN is 22.91%. ILMN's ROE for the same period is 12.11%. The trailing-twelve-month operating margin at Talecris Biotherapeutics Holdings Corp TLCR is 21.31%. TLCR's ROE for the same period is 40.27%. Trading Ideas.